Acorda Therapeutics

Acorda Therapeutics began in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological disorders. Everything Acorda does is aimed at improving the lives of millions of people with nervous system disorders and cardiovascular conditions in our local and global communities. In keeping with this mission, Acorda supports neurological and cardiovascular research, education, and patient assistance through grants and sponsorship programs. We also foster the next generation of scientists through the Acorda Scientific Excellence Award, which recognizes local high school students who are engaged in significant scientific, technological, engineering and mathematical (STEM) research. We are proud of our contributions in these areas, and we invite you to learn more about our company and our mission on this Facebook page and by visiting www.acorda.com.